The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Transgenic Fatal Familial Insomnia Mice Indicate Prion Infectivity-Independent Mechanisms of Pathogenesis and Phenotypic Expression of Disease
Open accessAbstract
Fatal familial insomnia (FFI) and a genetic form of Creutzfeldt-Jakob disease (CJD178) are clinically different prion disorders linked to the D178N prion protein (PrP) mutation. The disease phenotype is determined by the 129 M/V polymorphism on the mutant allele, which is thought to influence D178N PrP misfolding, leading to the formation of distinctive prion strains with specific neurotoxic properties. However, the mechanism by which misfolded variants of mutant PrP cause different diseases is not known. We generated transgenic (Tg) mice expressing the mouse PrP homolog of the FFI mutation. These mice synthesize a misfolded form of mutant PrP in their brains and develop a neurological illness with severe sleep disruption, highly reminiscent of FFI and different from that of analogously generated Tg(CJD) mice modeling CJD178. No prion infectivity was detectable in Tg(FFI) and Tg(CJD) brains by bioassay or protein misfolding cyclic amplification, indicating that mutant PrP has disease-encoding properties that do not depend on its ability to propagate its misfolded conformation. Tg(FFI) and Tg(CJD) neurons have different patterns of intracellular PrP accumulation associated with distinct morphological abnormalities of the endoplasmic reticulum and Golgi, suggesting that mutation-specific alterations of secretory transport may contribute to the disease phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures










![Fig 11 Tg(FFI) and Tg(CJD) neurons show different intracellular PrP accumulations and morphological abnormalities of transport organelles. Cultures of cerebellar granule neurons from non-Tg/Prnp +/+, Tg(FFI-K5+/-)/Prnp 0/0 and Tg(CJD-A21+/-)/Prnp 0/0 mice were fixed and labeled with anti-PrP monoclonal antibody 12B2 using the gold-enhance protocol. WT PrP is mostly found at the plasma membrane (A). D177N/M128 PrP is mostly in the Golgi (B), and D177N/V128 PrP is mostly in the ER, whose cisternae appear enlarged and swollen (C). Scale bar = 250 nm in A, B and C. (D) Quantification of gold particles in different cell compartments. PM, plasma membrane. (E) Quantification of ER and Golgi volumes of cultured cerebellar granule neurons. Data are the mean ± SD of at least 10 cells per specimen. Data for non-Tg/Prnp +/+ and Tg(CJD-A21+/-) neurons in D and E are from [14].](https://figures.cochat.ai/paper-figures/b66c865aa7604feeabc119734ab55c2e/transgenic-fatal-familial-insomnia-mice-indicate-prion-infectivity-independent-figure-11.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Fatal Prion Disease in a Mouse Model of Genetic E200K Creutzfeldt-Jakob Disease
Friedman‐Levi, Y., Meiner, Z., Canello, T., Frid, K., Kovács, G. G., Budka, H., Avrahami, D., & Gabizon, R. (2011) · PLoS Pathogens · doi:10.1371/journal.ppat.1002350 · Cited by 79 · cited 1×
“However, prion infectivity developed de novo even in Tg PrP mice with C57BL/6J X 129S5 [50], C57BL/6 X FVB [52], C57BL/6J X CBA/J X 129/Ola [21] and FVB [51, 53] backgrounds, suggesting that a specific allelic composition is not required.”
BackgroundRetractedFriedman‐Levi, Y., Mizrahi, M., Frid, K., Binyamin, O., & Gabizon, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069583 · Cited by 22 · cited 1×
“In contrast to the mitigating effect on sleep abnormalities, co-expression of WT PrP does not significantly modify the time of onset and progression of motor dysfunction or prolong survival of Tg(FFI) mice, consistent with the dominant mode of inheritance of FFI and with similar observations in other mutant PrP mice […”
ResultRetractedFiji: an open-source platform for biological-image analysis
Schindelin, J., Arganda-Carreras, I., Frise, E., Kaynig, V., Longair, M., Pietzsch, T., Preibisch, S., Rueden, C., Saalfeld, S., Schmid, B., et al. (2012) · Nature Methods · doi:10.1038/nmeth.2019 · Cited by 66,890 · cited 1×
“The volumes of the whole brain and individual brain areas (frontal cortex, hippocampus, thalamus, striatum and cerebellum) were quantified manually using Fiji software [79], after a rigid body registration (6 dof) to a reference image to avoid bias due to bad head positioning.”
MethodNovel Proteinaceous Infectious Particles Cause Scrapie
Prusiner, S. B. (1982) · Science · doi:10.1126/science.6801762 · Cited by 5,118 · cited 1×
“This is a conformationally altered and aggregated isoform of the cellular prion protein (PrP) which propagates by imprinting its aberrant conformation onto native PrP molecules [6].”
BackgroundTwo-Process Model of Sleep Regulation
(2009) · Encyclopedia of Neuroscience · doi:10.1007/978-3-540-29678-2_6166 · Cited by 3,899 · cited 2×
“Slow-wave activity (SWA) during NREM sleep (a measure of sleep drive and depth [17]) and EEG spindles (which characterize this sleep phase) were reduced in Tg(FFI)/Prnp mice.”
BackgroundGlutamate Receptor Ion Channels: Structure, Regulation, and Function
Traynelis, S. F., Wollmuth, L. P., McBain, C. J., Menniti, F. S., Vance, K. M., Ogden, K. K., Hansen, K. B., Yuan, H., Myers, S. J., & Dingledine, R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002451 · Cited by 3,568 · cited 13×
“Interestingly, the assembly and trafficking of these receptors are finely tuned in the ER and Golgi [74, 75].”
BackgroundInfluentialSelf-propagation of pathogenic protein aggregates in neurodegenerative diseases
Jucker, M., & Walker, L. C. (2013) · Nature · doi:10.1038/nature12481 · Cited by 1,663 · cited 1×
“There is evidence that aggregated proteins such as amyloid-β in AD, tau in the tauopathies, and α-synuclein in PD, are able to spread in a prion-like manner when inoculated into the mouse brain [62].”
BackgroundNormal development and behaviour of mice lacking the neuronal cell-surface PrP protein
Büeler, H., Fischer, M., Lang, Y., Bluethmann, H., Lipp, H.-P., DeArmond, S. J., Prusiner, S. B., Aguet, M., & Weissmann, C. (1992) · Nature · doi:10.1038/356577a0 · Cited by 1,655 · cited 1×
“Transgenic founders were bred with an inbred colony of Zürich I Prnp mice [77] with a pure C57BL/6J background (C57BL/6J/Prnp; European Mouse Mutant Archive, Monterotondo, Rome, Italy; EM:01723).”
BackgroundPrion Diseases of Humans and Animals: Their Causes and Molecular Basis
Collinge, J. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.519 · Cited by 1,344 · cited 1×
“Prion diseases are progressive and invariably fatal degenerative disorders of the central nervous system (CNS) that affect humans and other animals [1].”
BackgroundThe cell biology of synaptic plasticity: AMPA receptor trafficking
Shepherd, J. D., & Huganir, R. L. (2007) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.23.090506.123516 · Cited by 978 · cited 13×
“Interestingly, the assembly and trafficking of these receptors are finely tuned in the ER and Golgi [74, 75].”
BackgroundInfluential
Cited by
Quantifying prion disease penetrance using large population control cohorts
Minikel, E. V., Vallabh, S. M., Lek, M., Estrada, K., Samocha, K. E., Sathirapongsasuti, J. F., McLean, C. Y., Tung, J. Y., Yu, L. P. C., Gambetti, P., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad5169 · Cited by 442
Induction of a transmissible tau pathology by traumatic brain injury
Zanier, E. R., Bertani, I., Sammali, E., Pischiutta, F., Chiaravalloti, M. A., Vegliante, G., Masone, A., Corbelli, A., Smith, D. H., Menon, D. K., et al. (2018) · Brain · doi:10.1093/brain/awy193 · Cited by 136
“, 2016) and prion inoculation in mice (Bouybayoune et al., 2015)].”
BackgroundSelf-citationFatal familial insomnia and sporadic fatal insomnia
Cracco, L., Appleby, B. S., & Gambetti, P. L. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63945-5.00015-5 · Cited by 105
Most sleep does not serve a vital function: Evidence from Drosophila melanogaster
Geissmann, Q., Beckwith, E. J., & Gilestro, G. F. (2019) · Science Advances · doi:10.1126/sciadv.aau9253 · Cited by 75
Fatal Familial Insomnia: Clinical Aspects and Molecular Alterations
Llorens, F., Zarranz, J. J., Fischer, A., Zerr, I., & Ferrer, I. (2017) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-017-0743-0 · Cited by 70
O’Melia, M. J., Manspeaker, M. P., & Thomas, S. N. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-020-02792-5 · Cited by 75
Pensinger, D. A., Boldon, K. M., Chen, G. Y., Vincent, W. J. B., Kyle, S., Xiong, M., Schaenzer, A. J., Forster, E. R., Coers, J., Striker, R., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1006001 · Cited by 73
Bertani, I., Iori, V., Trusel, M., Maroso, M., Foray, C., Mantovani, S., Tonini, R., Vezzani, A., & Chiesa, R. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.1301-17.2017 · Cited by 58
Self-citationCellular Prion Protein (PrPc): Putative Interacting Partners and Consequences of the Interaction
Miranzadeh Mahabadi, H., & Taghibiglou, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197058 · Cited by 52
“Prion-related diseases can be caused by point mutations or insertions in the gene encoding PrPc leading to PrPc misfolding in the ER and its retention in the secretory pathway [189,267,268].”
BackgroundGao, L., Shi, Q., Xiao, K., Wang, J., Zhou, W., Chen, C., & Dong, X. (2019) · Scientific Reports · doi:10.1038/s41598-019-38520-y · Cited by 51
The Elusive Role of the Prion Protein and the Mechanism of Toxicity in Prion Disease
Chiesa, R. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004745 · Cited by 56
Self-citationGrande, V., Ornaghi, F., Comerio, L., Restelli, E., Masone, A., Corbelli, A., Tolomeo, D., Capone, V., Axten, J. M., Laping, N. J., et al. (2018) · Human Molecular Genetics · doi:10.1093/hmg/ddy152 · Cited by 50
Self-citationTowards authentic transgenic mouse models of heritable PrP prion diseases
Watts, J. C., Giles, K., Bourkas, M. E. C., Patel, S. S., Oehler, A., Gavidia, M., Bhardwaj, S., Lee, J., & Prusiner, S. B. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1585-6 · Cited by 52
“Such disturbances have been found in two mouse models expressing FFI-mutant MoPrP despite the absence of FFI-like PK-resistant PrP species in their brains [6, 23].”
BackgroundPuig, B., Altmeppen, H. C., Linsenmeier, L., Chakroun, K., Wegwitz, F., Piontek, U. K., Tatzelt, J., Bate, C., Magnus, T. U., & Glatzel, M. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007520 · Cited by 52
Identification of new molecular alterations in fatal familial insomnia
Llorens, F., Thüne, K., Schmitz, M., Ansoleaga, B., Frau‐Méndez, M. A., Cramm, M., Tahir, W., Gotzmann, N., Berjaoui, S., Carmona, M., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw108 · Cited by 46
“Transgenic models carrying the D178N mutation have been useful to learn about the effects of this mutation in brain as lesions are reminiscent of those seen in FFI despite conflicting data regarding the generation of transmissible prions (24,25).”
BackgroundMethodKho, K., & Meredith, T. C. (2018) · Journal of Bacteriology · doi:10.1128/jb.00017-18 · Cited by 47
MouR controls the expression of the Listeria monocytogenes Agr system and mediates virulence
Pinheiro, J. C., Lisboa, J., Pombinho, R., Carvalho, F., Carreaux, A., Brito, C., Pöntinen, A. K., Korkeala, H. J., dos Santos, N. M. S., Morais-Cabral, J. H., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky624 · Cited by 47
Experimental Models of Inherited PrP Prion DiseasesPreprint
Watts, J. C., & Prusiner, S. B. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027151 · Cited by 38
“FFI-26 mice, which express mutant PrP at 2 levels, developed a progressive neurological disease at 200 d of age that was characterized by ataxia and kyphosis (Bouybayoune et al. 2015).”
BackgroundInfluentialMironov, A., Sesorova, I. S., Seliverstova, E., & Beznoussenko, G. (2017) · Tissue & Cell · doi:10.1016/j.tice.2016.12.002 · Cited by 30
Self-citationPuig, B., Altmeppen, H. C., Ulbrich, S., Linsenmeier, L., Krasemann, S., Chakroun, K., Acevedo-Morantes, C., Wille, H., Tatzelt, J., & Glatzel, M. (2016) · Scientific Reports · doi:10.1038/srep24970 · Cited by 34
Moreno, J. A., & Telling, G. C. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7244-9_16 · Cited by 31
Mutant prion proteins increase calcium permeability of AMPA receptors, exacerbating excitotoxicity
Ghirardini, E., Restelli, E., Morini, R., Bertani, I., Ortolan, D., Perrucci, F., Pozzi, D., Matteoli, M., & Chiesa, R. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1008654 · Cited by 30
Self-citationComoy, E. E., Mikol, J., Jaffré, N., Lebon, V., Levavasseur, E., Streichenberger, N., Sumian, C. C., Perret‐Liaudet, A., Éloit, M., Andréoletti, O., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01347-0 · Cited by 31
Salmi, M., Gallo, F. D., Minlebaev, M., Zakharov, A., Pauly, V., Perron, P., Pons-Bennaceur, A., Corby-Pellegrino, S., Aniksztejn, L., Lenck‐Santini, P., et al. (2019) · Epilepsia · doi:10.1111/epi.16060 · Cited by 30
Panel), E. P. O. B. H. (. (2015) · EFSA Journal · doi:10.2903/j.efsa.2015.4197 · Cited by 30
“FFI and a genetic form of Creutzfeldt-Jakob disease (CJD178) are clinically different prion disorders linked to the D178N PrP mutation (Bouybayoune et al., 2015).”
BackgroundZhang, J., Chu, M. K., Tian, Z., Xie, K., Cui, Y., Liu, L., Meng, J., Yan, H., Ji, Y.-M., Jiang, Z., et al. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2021-327247 · Cited by 28
Eraña, H., Díaz‐Domínguez, C. M., Charco, J. M., Vidal, E., González-Miranda, E., Pérez‐Castro, M. A., Piñeiro, P., López-Moreno, R., Sampedro-Torres-Quevedo, C., Fernández-Veiga, L., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01640-8 · Cited by 22
“However, the diseases developed in such transgenic animals have proven to be poorly transmissible, if at all, in wild-type animals [9, 35, 43, 76].”
BackgroundSelf-citationRace, B., Williams, K., Hughson, A. G., Jansen, C., Parchi, P., Rozemüller, A. J. M., & Chesebro, B. W. (2018) · Acta Neuropathologica Communications · doi:10.1186/s40478-018-0516-2 · Cited by 22
“Transmissible prion infectivity has been found in some, but not all, of these models [1, 12, 21, 49], suggesting that presence of prion infectivity is not absolutely required for the development of these signs of clinical neurological disease.”
Manipulating the Prion Protein Gene Sequence and Expression Levels with CRISPR/Cas9
Kaczmarczyk, L., Mende, Y., Zevnik, B., & Jackson, W. S. (2016) · PLoS ONE · doi:10.1371/journal.pone.0154604 · Cited by 25
“For example, the mutation causing FFI does not always cause a neurodegenerative phenotype when expressed as a RIT, even when the gene product is present several fold higher than when expressed from the endogenous Prnp locus, a context in which the mutant gene is toxic [29,32].”
BackgroundTransgenic Mouse Models for the Study of Neurodegenerative Diseases
Marín‐Moreno, A., Canoyra, S., Fernández‐Borges, N., Espinosa, J. C., & Torres, J. M. (2023) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2801021 · Cited by 22
“[203,204,207–225]).”
Self-citationTherapeutic Trial of anle138b in Mouse Models of Genetic Prion Disease
Vallabh, S. M., Zou, D., Pitstick, R., O’Moore, J., Peters, J., Silvius, D., Križ, J., Jackson, W. S., Carlson, G. A., Minikel, E. V., et al. (2023) · Journal of Virology · doi:10.1128/jvi.01672-22 · Cited by 23
Chiesa, R., Restelli, E., Comerio, L., Gallo, F. D., & Imeri, L. (2016) · Prion · doi:10.1080/19336896.2016.1139276 · Cited by 20
“In contrast, Tg(FFI) mice expressing mutant PrP at twice the endogenous level or more developed a progressive and invariably fatal neurological disease, and accumulated detergent-insoluble, protease-resistant PrP in their brains, yielding a 19 kDa C-terminal fragment after mild PK digestion and deglycosylation, like i…”
BackgroundMethodInfluentialSelf-citationClinical Trial Research on Mongolian Medical Warm Acupuncture in Treating Insomnia
Bo, A., Si, L., Wang, Y., Xiu, L., Wu, R., Li, Y., Mu, R., Ga, L., Miao, M., Fu, S., et al. (2016) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2016/6190285 · Cited by 19
“The pathogenic mechanisms of insomnia are complex and many of them still remain unclear [15].”
BackgroundFoliaki, S. T., Smith, A., Schwarz, B. H., Bohrnsen, E., Bosio, C. M., Williams, K., Orru, C. D., Lachenauer, H., Groveman, B. R., & Haigh, C. L. (2023) · PLoS Genetics · doi:10.1371/journal.pgen.1010565 · Cited by 23
“As reported previously in mouse models of FFI [4, 5], we observed increased levels of di-glycosylated PrP in the DN COs (Fig 1F), suggesting that the mutation altered the post-translational modification of PrP.”
BackgroundA tetracationic porphyrin with dual anti-prion activity
Masone, A., Zucchelli, C., Caruso, E., Lavigna, G., Eraña, H., Giachin, G., Tapella, L., Comerio, L., Restelli, E., Raimondi, I., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107480 · Cited by 18
“For low-resolution structural models, an Ensemble Optimization Method (EOM) analysis was conducted, treating the globular domain (125-228) as a rigid body derived from the huPrP90-230 NMR structure 1QM0 (PDB id) and modeling the N-terminal tail (23-124) by EOM.”
MethodSelf-citationExperimental models to study prion disease pathogenesis and identify potential therapeutic compounds
Vorberg, I. M., & Chiesa, R. (2019) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2019.02.002 · Cited by 16
Self-citationElezgarai, S. R., Fernández‐Borges, N., Eraña, H., Sevillano, A. M., Charco, J. M., Harrathi, C., Saá, P., Gil‐Carton, D., Kong, Q., Requena, J. R., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09489-3 · Cited by 14
Self-citationThe Role of the Mammalian Prion Protein in the Control of Sleep
Roguski, A., & Gill, A. C. (2017) · Pathogens · doi:10.3390/pathogens6040058 · Cited by 16
“However, changes in circadian-regulated motor activity of these mice, including decreased dark-phase activity compared to controls [34], are not readily rationalized by thalamic degeneration and knock-in FFI mice also show significant decreases in dark-phase motor activity compared to controls [35].”
BackgroundConvergent generation of atypical prions in knockin mouse models of genetic prion disease
Mehra, S., Bourkas, M. E. C., Kaczmarczyk, L., Stuart, E., Arshad, H., Griffin, J. K., Frost, K. L., Walsh, D. J., Supattapone, S., Booth, S. A., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci176344 · Cited by 13
“While Most cases of human prion disease arise due to spontaneous misfolding of WT or mutant prion protein, yet recapitulating this event in animal models has proven challenging.”
BackgroundVirus Infection, Genetic Mutations, and Prion Infection in Prion Protein Conversion
Hara, H., & Sakaguchi, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212439 · Cited by 13
Bona fide atypical scrapie faithfully reproduced for the first time in a rodent model
Vidal, E., Sánchez‐Martín, M., Eraña, H., Lázaro, S. P., Pérez‐Castro, M. A., Otero, A., Charco, J. M., Marín, B., López-Moreno, R., Díaz‐Domínguez, C. M., et al. (2022) · Acta Neuropathologica Communications · doi:10.1186/s40478-022-01477-7 · Cited by 16
“These include the ki3F4-FFI mice that harbour the D177N mutation, equivalent to the human mutation responsible for FFI [43] and the D178N Tg(FFI) also reproducing FFI phenotype [14], the Tg(A116V) mice mimicking A117V GSS [84], the TgMHuME199K mimicking E200K genetic CJD [30], the 113LBoPrP-Tg mice that incorporated t…”
BackgroundSelf-citationThe utility of bank voles for studying prion disease
Arshad, H., Bourkas, M. E. C., & Watts, J. C. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.009 · Cited by 13
Transgenic mouse models for the study of prion diseases
Marín‐Moreno, A., Espinosa, J. C., & Torres, J. M. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.007 · Cited by 12
C. elegans detects toxicity of traumatic brain injury generated tau
Zanier, E. R., Barzago, M. M., Vegliante, G., Romeo, M., Restelli, E., Bertani, I., Natale, C., Colnaghi, L., Colombo, L., Russo, L., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105330 · Cited by 13
“This suggests a dissociation between the toxic and self-propagating species of tau, much like the dissociation between the toxic and infectious PrP species in the prototypical prion diseases (Benilova et al., 2020; Bouybayoune et al., 2015; Chiesa et al., 2003; Sandberg et al., 2011).”
BackgroundSelf-citationLavigna, G., Masone, A., Bouybayoune, I., Bertani, I., Lucchetti, J., Gobbi, M., Porcu, L., Zordan, S., Rigamonti, M., Imeri, L., et al. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105455 · Cited by 12
“We found that non-Tg mice did not differ from C57BL/6 in motor behavior, cognitive function, sleep and motor circadian rhythmicity (Bouybayoune et al., 2015).”
BackgroundMethodInfluentialSelf-citationDisorder of Golgi Apparatus Precedes Anoxia-Induced Pathology of Mitochondria
Morozov, Y. M., & RAKIC, P. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054432 · Cited by 9
“These mutant mice also show reduced thalamic and cerebellar volumes—reminiscent of human neuropathology—as well as disease phenotypes such as sleep abnormalities, motor ataxia, and impaired spatial working memory [28].”
BackgroundResultInfluentialGojanovich, A. D., Le, N. T. T., Mercer, R. C. C., Park, S., Wu, B., Anane, A., Vultaggio, J. S., Mostoslavsky, G., & Harris, D. A. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.08.010 · Cited by 11
Sleep inhibition induced by amyloid‐β oligomers is mediated by the cellular prion protein
Gallo, F. D., Bianchi, S., Bertani, I., Messa, M., Colombo, L., Balducci, C., Salmona, M., Imeri, L., & Chiesa, R. (2020) · Journal of Sleep Research · doi:10.1111/jsr.13187 · Cited by 12
“Although scoring epochs lasting 10 s (Davis et al., 2015; Kroeger et al., 2018; Sutton & Opp, 2014) or 12 s (Bouybayoune et al., 2015; Dossena et al., 2008) are used in mice, we acknowledge the limitations of the scoring epoch length (12 s) used in this study.”
BackgroundMethodSelf-citationThe importance of prion research
Eid, S., Lee, S., Verkuyl, C. E., Almanza, D. L., Hanna, J., Shenouda, S., Belotserkovsky, A., Zhao, W., & Watts, J. C. (2024) · Biochemistry and Cell Biology · doi:10.1139/bcb-2024-0018 · Cited by 10
Bistaffa, E., Marín‐Moreno, A., Espinosa, J. C., Luca, C. M. G. D., Cazzaniga, F. A., Portaleone, S. M., Celauro, L., Legname, G., Giaccone, G., Torres, J. M., et al. (2021) · eLife · doi:10.7554/elife.65311 · Cited by 8
Genetic human prion disease modelled in PrP transgenic Drosophila
Thackray, A. M., Cardova, A., Wolf, H., Pradl, L., Vorberg, I. M., Jackson, W. S., & Bujdoso, R. (2017) · Biochemical Journal · doi:10.1042/bcj20170462 · Cited by 9
Emerging Evidence of Golgi Stress Signaling for Neuropathies
Shirai, R., & Yamauchi, J. (2024) · Neurology International · doi:10.3390/neurolint16020024 · Cited by 7
Calcineurin Controls Cellular Prion Protein Expression in Mouse Astrocytes
Dematteis, G., Restelli, E., Vanella, V. V., Manfredi, M., Marengo, E., Corazzari, M., Genazzani, A. A., Chiesa, R., Lim, D., & Tapella, L. (2022) · Cells · doi:10.3390/cells11040609 · Cited by 7
“Since prion diseases include genetic variants caused by mutations in the PrP gene, including the PrPD177N mutation associated with FFI human disease [31,46,57,58], it was of interest to investigate whether the effect of CaN KO in astrocytes differs between wildtype PrPC and the mutant variant.”
BackgroundSelf-citationMercer, R. C. C., McDonald, A. J., Bove‐Fenderson, E., Fang, C., Wu, B., & Harris, D. A. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811304-2.00002-x · Cited by 5
Total Wake: Natural, Pathological, and Experimental Limits to Sleep Reduction
Panchin, Y. V., & Kovalzon, V. M. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.643496 · Cited by 5
“Knockin mice expressing human FFI-specific PRNP mutations develop some abnormalities reminiscent of the human disease, but not agrypnia (Jackson et al., 2009; Bouybayoune et al., 2015).”
BackgroundLosing sleep over mitochondria: a new player in the pathophysiology of fatal familial insomnia
Glatzel, M., & Falla, D. S. (2016) · Brain Pathology · doi:10.1111/bpa.12410 · Cited by 5
“Additionally, this mutation affects maturation of the protein and leads to retention in the biosynthetic pathway (2).”
BackgroundResultActivation of Src family kinase ameliorates secretory trafficking in mutant prion protein cells
Restelli, E., Capone, V., Pozzoli, M., Ortolan, D., Quaglio, E., Corbelli, A., Fiordaliso, F., Beznoussenko, G. V., Artuso, V., Roiter, I., et al. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100490 · Cited by 6
“Subcellular localization of PG14, CJD, and FFI PrPs in HeLa cells confirmed previous observations in primary neurons and neuroblastoma N2a cells, indicating mutation-specific differences in intracellular PrP distribution (3, 4, 6, 10, 12).”
BackgroundMethodResultSelf-citationLavigna, G., Grasso, A., Pasini, C., Grande, V., Mignogna, L., Restelli, E., Masone, A., Fracasso, C., Lucchetti, J., Gobbi, M., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0317404 · Cited by 5
Self-citationWu, Y.-Z., Gao, L., Chen, D., Liang, D.-L., Chen, J., Xiao, K., Hu, C., Chen, C., Shi, Q., & Dong, X. (2023) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2023.07.024 · Cited by 3
Prion propagation and cellular dysfunction in prion disease: Disconnecting the dots
Foliaki, S. T., & Haigh, C. L. (2023) · PLoS Pathogens · doi:10.1371/journal.ppat.1011714 · Cited by 3
Experimental models of human prion diseases and prion strains
Diack, A. B., & Bartz, J. C. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63945-5.00004-0 · Cited by 3
Pros and cons in prion diseases abatement: Insights from nanomedicine and transmissibility patterns
Chandrasekaran, M., Manivannan, P., & Muralitharan, G. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.12.150 · Cited by 3
Misfolding leads the way to unraveling signaling pathways in the pathophysiology of prion diseases
Puig, B., Altmeppen, H. C., & Glatzel, M. (2016) · Prion · doi:10.1080/19336896.2016.1244593 · Cited by 3
Staff, T. P. P. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005046 · Cited by 3
Infecting human brain organoids with FFI or sCJD preserves prion traits regardless of host genotype
Groveman, B. R., Foliaki, S. T., Williams, K., Orru, C. D., Race, B., Zanusso, G., & Haigh, C. L. (2025) · npj Dementia · doi:10.1038/s44400-025-00029-9 · Cited by 2
“10.”
The Role of the Golgi Apparatus in Neurodegeneration
Shadfar, S., Kashani, S. A., Gautam, S., Takalloo, Z., Farzana, F., Parakh, S., & Atkin, J. D. (2026) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-3-032-16833-7_17 · Cited by 2
Cyclophillin A deficiency accelerates RML-induced prion disease
Bouybayoune, I., Comerio, L., Pasetto, L., Bertani, I., Bonetto, V., & Chiesa, R. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104498 · Cited by 2
Self-citationFactors influencing protein misfolding and aggregate formation that triggers neuronal cell death
Singh, A., Deshpande, P., Chimata, A. V., Subramanian, M., Sangeeth, A., Baajpai, S., Padma, R., & Singh, A. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-18716-2.00001-6 · Cited by 2
Gene-Edited Cell Models to Study Chronic Wasting Disease
Thapa, S., Marrero-Winkens, C., Tahir, W., Arifin, M. I., Gilch, S., & Schätzl, H. M. (2022) · Viruses · doi:10.3390/v14030609 · Cited by 1
Gallo, F. D., Salari, V., Maggia, M., Salmi, M., Bentivoglio, M., Fabene, P. F., Szepetowski, P., & Bertini, G. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2025.1694773 · Cited by 1
Clinical features, pathophysiology and management of fatal familial insomnia
Redaelli, V., Tagliavini, F., & Moda, F. (2017) · Expert Opinion on Orphan Drugs · doi:10.1080/21678707.2017.1311251
“As predicted, PrP was barely detected in the brain of these animals after PK digestion [86,87].”
BackgroundSelf-citationTransgenic Mouse Models of Prion Diseases
Moreno, J. A., & Telling, G. C. (2017) · Neuromethods · doi:10.1007/978-1-4939-7211-1_16
Drosophila Models of Prion Diseases
Myers, R. R., & Fernández-Fúnez, P. (2023) · Springer eBooks · doi:10.1007/978-3-031-20565-1_17
Miscellaneous CNS Viral Infections: Underappreciated Causes of Neurologic Disease
Sami, H., Firoze, S., & Khan, P. A. (2023) · Springer eBooks · doi:10.1007/978-981-99-6445-1_11
Kasbi, N. A., & Stüve, O. (2025) · Current Treatment Options in Neurology · doi:10.1007/s11940-024-00821-7
“This potential role is supported by its interaction with α 2 δ−1 subunit of voltage-gated calcium channels [141, 142], lactate dehydrogenase A (LDHA) [143], casein Kinase II (CK2) [144, 145], plasminogen [146, 147], neuronal nitric oxide synthase (nNOS) [148], caveolin-1 [149, 150], copper, zinc,…”
Vidal, E., Sánchez-Martín, M. A., Eraña, H., Lázaro, S. P., Pérez‐Castro, M. A., Otero, A., Charco, J. M., Marín, B., López-Moreno, R., Díaz‐Domínguez, C. M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26554145
Self-citationEraña, H., Díaz‐Domínguez, C. M., Charco, J. M., Vidal, E., González-Miranda, E., Pérez‐Castro, M. A., Piñeiro, P., López-Moreno, R., Sampedro-Torres-Quevedo, C., Fernández-Veiga, L., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26615599
Self-citationMasone, A., Grasso, A., Comerio, L., Bruno, R., Lavigna, G., Vanni, I., D’Agostino, C., Orru, C. D., Caughey, B., Altmeppen, H. C., et al. (2026) · Acta Neuropathologica · doi:10.1007/s00401-026-02976-w
“Additionally, no prion seeding activity was detected in the brains of Tg(FFI) and Tg(CJD) mice by serial protein mis-folding cyclic amplification (PMCA), which allows highly efficient PrP Sc amplification in vitro [5].”
InfluentialSelf-citationHaloTag Fusion Enables Dynamic Analysis of Prion Protein Biosynthesis, Turnover, and Misfolding
Masone, A., Busani, E., & Chiesa, R. (2026) · ChemBioChem · doi:10.1002/cbic.202500831
“This approach allows detec tion of mildly protease - resistant PrP species previously described in cells and mice expressing the untagged or EGFP - tagged mutant PrPs [6, 7, 24, 25, 27, 28, 30, 32].”
Self-citation
Metadata
- Authors
- Bouybayoune, I., Mantovani, S., Del Gallo, F., Bertani, I., Restelli, E., Comerio, L., Tapella, L., Baracchi, F., Fernández-Borges, N., Mangieri, M., Bisighini, C., Beznoussenko, G. V., Paladini, A., Balducci, C., Micotti, E., Forloni, G., Castilla, J., Fiordaliso, F., Tagliavini, F., Imeri, L., & Chiesa, R.
- Affiliations
- Mario Negri Institute for Pharmacological Research (IT)
- University of Milan (IT)
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- IFOM (IT)
- Corresponding author
- Chiesa, Roberto
- ORCID
- Venue
- PLOS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-04-16
- Volume
- 11
- Issue
- 4
- Pages
- e1004796
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC4400166
- OpenAlex
- W2064229986
- Cited by
- 81
- References
- 83
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 6 · 2023: 11 · 2022: 3 · 2021: 8 · 2020: 5 · 2019: 7 · 2018: 9 · 2017: 10 · 2016: 11 · 2015: 3
- FWCI
- 4.78
- Type
- journal article
- Language
- en
- Update notices
- correction (2015-07-06)
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Fondazione Cariplo (2012-0560, RF-INN-2008-1215065, TDRC00508TU, 2010-0828, RF-2010-2314035)
- Ministero della Salute (RF 2010, TDRC00508TU, RF-2010-2314035, 2010-0828, RF-INN-2008-1215065)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Prion Diseases and Protein Misfolding
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Internal Medicine › Amyloidosis: Diagnosis, Treatment, Outcomes
- Keywords
- fatal familial insomnia, Creutzfeldt-Jakob disease, transgenic mice, prion protein misfolding, prion strains, sleep disruption, endoplasmic reticulum, Golgi apparatus, secretory transport, neurodegeneration
- MeSH terms
- Prion Proteins, Animals, Brain, Disease Models, Animal, Electroencephalography, Magnetic Resonance Imaging, Mice, Inbred C57BL, Mice, Transgenic, Mutation, Phenotype, Prions, Maze Learning, Insomnia, Fatal Familial, Microscopy, Electron, Transmission, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.